ARCH VENTURE FUND XII, L.P. - PRIME MEDICINE -- SCH 13D

Company

Prime Medicine, Inc.

Filed

February 22, 2024

Accession Number

0001072613-24-000265

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →